Specifically, glial cells are broadly recognized as important modulators of ALS, which can be observed in the fact that transplanted wildtype microglia delays disease progression in ALS models [97] and the fact that selective deletion of mutant SOD1 in astrocytes affects disease progression but not its onset [98]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.